Liver Cancer News and Research

RSS
Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
Turmeric may be 'the right spice' to fight colon cancer

Turmeric may be 'the right spice' to fight colon cancer

Genetic variants determine severity of HCV-related graft disease and antiviral treatment response

Genetic variants determine severity of HCV-related graft disease and antiviral treatment response

Wako receives FDA 510(k) clearance for uTASWako i30 with AFP-L3 and DCP assays

Wako receives FDA 510(k) clearance for uTASWako i30 with AFP-L3 and DCP assays

Bristol-Myers Squibb awards $1 million grant to reduce hepatitis-related health disparities in Asia

Bristol-Myers Squibb awards $1 million grant to reduce hepatitis-related health disparities in Asia

New research: Significant number of HCV patients in the U.S. does not have health insurance coverage

New research: Significant number of HCV patients in the U.S. does not have health insurance coverage

Lack of health insurance limits Hepatitis C patients' access to latest antiviral therapy

Lack of health insurance limits Hepatitis C patients' access to latest antiviral therapy

Onyx, Bayer initiate patient enrollment in Nexavar Phase 3 trial for breast cancer treatment

Onyx, Bayer initiate patient enrollment in Nexavar Phase 3 trial for breast cancer treatment

New vaccine offers hope against Hepatitis C

New vaccine offers hope against Hepatitis C

Cerasome filled molecular-sized bubbles to target liver cancer cells

Cerasome filled molecular-sized bubbles to target liver cancer cells

First robotically-assisted liver resection performed at Jefferson University Hospital

First robotically-assisted liver resection performed at Jefferson University Hospital

Apricus Bio in discussions with FDA for PrevOnco SPA Phase III protocol

Apricus Bio in discussions with FDA for PrevOnco SPA Phase III protocol

CPIC scientists find rates of liver cancer in US-born Hispanic men increased by 87%

CPIC scientists find rates of liver cancer in US-born Hispanic men increased by 87%

Two Uofl professors provide reference works in oncology field

Two Uofl professors provide reference works in oncology field

Aushon BioSystems enters diagnostic development collaboration with Peking University Cancer Hospital

Aushon BioSystems enters diagnostic development collaboration with Peking University Cancer Hospital

LESSOnc technique promising new surgical option for certain liver cancers

LESSOnc technique promising new surgical option for certain liver cancers

Study finds heartburn as a common condition in Iceland

Study finds heartburn as a common condition in Iceland

Fast track rehabilitation program effective after colorectal surgery

Fast track rehabilitation program effective after colorectal surgery

Study on non-surgical approach for treatment of liver hydatidosis

Study on non-surgical approach for treatment of liver hydatidosis

American Cancer Society report released on World Cancer Day

American Cancer Society report released on World Cancer Day

More needs to be done globally to fight cancer

More needs to be done globally to fight cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.